This retrospective study aims to analyze the impact of postoperative changes in serum uric acid (SUA) levels on the prognosis of patients undergoing pancreatic cancer resection.
Patients with pathologically confirmed pancreatic cancer (primary)
Patients who underwent Radical resection of pancreatic cancer（Pancreaticoduodenectomy or Distal pancreatectomy）
The postoperative survival time was at least 6 weeks
No surgery was performed, or only palliative surgery/ biopsy was performed
Patients who underwent emergency hemodialysis or plasma exchange after surgery
History of gout or long-term urate-lowering therapy, such as allopurinol
Patients are missing follow-up data